← Leaderboards
Luksana Chaiswing
University Of Kentucky
$2,437,340
Attributed
$2,597,818
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $414.7K · FY2015–25$500K$375K$250K$125K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,597,818 · 3
By mechanism
R01$1,906,181 · 1
R21$370,681 · 1
P20$320,956 · 1
Top collaborators
- Binhua P Zhou1 shared
Most similar at University Of Kentucky
Same institution · by research overlap
- Zhiming Zhang$5,043,972
- Sheng Tong$2,577,964
- Andrew N Lane$6,700,927
- Ming C Gong$10,288,417
- Zhenheng Guo$9,758,888
Others in their field
Top investigators on “Malignant Neoplasm Of Prostate”
- David Heimbrook · Leidos Biomedical Research, Inc.$255,843,614
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,277,106
- Walter John Curran · Thomas Jefferson University$61,298,085
- Norman Wolmark · Nsabp Foundation, Inc.$54,888,134
- James J. Dignam · University Of Chicago$48,310,409
- Laurence H Baker · University Of Michigan At Ann Arbor$43,366,962
Research focus
Malignant Neoplasm Of ProstateCellsCessation Of LifeMolecularTumorReactive Oxygen SpeciesProteinsSiteResolutionResponseMagnetic Resonance ImagingBiochemicalMalignant NeoplasmsProstateOxidation-ReductionImageExhibitsOverexpressionMetabolicIn VivoPropertyMitochondriaAntibioticsMitochondrial Metabolism
Grant awards (11)
Targeting Mitochondrial Redox Capacity to Overcome Cancer Subtype that Regrowth After Radiation$349,988
R01 · FY2025 · CA · contact PI
Targeting Mitochondrial Redox Capacity to Overcome Cancer Subtype that Regrowth After Radiation$64,663
R01 · FY2025 · CA · contact PI
Targeting Mitochondrial Redox Capacity to Overcome Cancer Subtype that Regrowth After Radiation$332,489
R01 · FY2024 · CA · contact PI
Targeting Mitochondrial Redox Capacity to Overcome Cancer Subtype that Regrowth After Radiation$61,429
R01 · FY2024 · CA · contact PI
Targeting Mitochondrial Redox Capacity to Overcome Cancer Subtype that Regrowth After Radiation$342,988
R01 · FY2023 · CA · contact PI
Targeting Mitochondrial Redox Capacity to Overcome Cancer Subtype that Regrowth After Radiation$61,648
R01 · FY2023 · CA · contact PI
Targeting Mitochondrial Redox Capacity to Overcome Cancer Subtype that Regrowth After Radiation$342,988
R01 · FY2022 · CA · contact PI
Targeting Mitochondrial Redox Capacity to Overcome Cancer Subtype that Regrowth After Radiation$349,988
R01 · FY2021 · CA · contact PI
Mitochondrial Heat Shock Protein 90 as a Novel Target for Radiation Resistant Prostate Cancer Treatment$320,956
P20 · FY2020 · GM · contact PI
Oxidized redox state, a new potential biomarker for prostate cancer progression$206,202
R21 · FY2016 · CA · contact PI
Oxidized redox state, a new potential biomarker for prostate cancer progression$164,479
R21 · FY2015 · CA · contact PI